This potential neuroprotective role of VEGF has been confirmed in AD mouse models, where brain injections of VEGF‐producing nanoparticles, microcapsules, or mesenchymal stem cells reduced brain Aβ load and learning and memory impairments (Garcia et al., 2014; Herrán et al., 2013; Spuch et al., 2010). Here, VEGFA is linked to Alzheimer disease.